Medical Diagnositic

BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation ...Read more

06th February, 2025


TriLink BioTechnologies® and Aldevron sign agreement for CleanCap® mRNA Capping Technology

The non-exclusive license and supply deal aims to enhance mRNA manufacturing efficiency and scalability....Read more

05th February, 2025


FDA approves Roche’s Susvimo as first continuous delivery treatment for Diabetes-Related Blindness

Susvimo becomes the only FDA-approved therapy offering continuous drug delivery for diabetic eye disease....Read more

05th February, 2025


Onco-Innovations Acquires Inka Health to Boost AI-Driven Cancer Research

Strategic move aims to accelerate advancements in cancer detection and drug development....Read more

04th February, 2025


Median Technologies' eyonis™ LCS Achieves Primary Endpoint in RELIVE Trial

Successful results from the pivotal study pave the way for regulatory submissions in lung cancer screening....Read more

03rd February, 2025


Middle East: A rising powerhouse in Medtech and Diagnostics

The Middle East's medtech and diagnostics sector is undergoing a dynamic transformation, fuelled by rapid technological advancements and strategic healthcare investments. This burgeoning industry is poised for significan...Read more

03rd February, 2025


Accelerating Cancer Treatment with Precision Medicine & NGS

Asia accounts for nearly half of global cancer cases, making it a major health concern. Recognising the promise of precision oncology, governments across the region have initiated efforts to drive advancements in this sp...Read more

03rd February, 2025


DRG Launches Innovative TBI Test Panel at MEDLAB Dubai

The new test panel aims to revolutionize traumatic brain injury detection with advanced diagnostic capabilities....Read more

03rd February, 2025


Vertex Secures FDA Approval for JOURNAVX™ (suzetrigine), a Novel Non-Opioid Treatment for Acute Pain

JOURNAVX™ introduces a first-in-class approach to managing moderate-to-severe acute pain, offering an alternative to traditional opioid therapies....Read more

31st January, 2025


Diag-Nose.io ssecures $2M Seed Funding to Revolutionize Respiratory Care with AI-Powered Precision Medicine

A graduate of CDL-Seattle, Diag-Nose.io aims to enhance respiratory disease diagnosis and treatment through advanced AI-driven solutions....Read more

31st January, 2025


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer